alpha-MSH analogue raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-06-11. Anything still debated is marked as such rather than presented as settled.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Free base; salt forms differ |
| Molecular weight | Approximately 1024 g/mol | Calculated for the free base |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water and polar solvents | Poorly soluble in non-polar solvents |
| Typical storage | -20 degrees Celsius, dry, protected from light | Refers to the solid form |
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.
==== Experiment in virus ==== Gong et al. collected obtained genotype data of influenza nucleoprotein from different timelines and temporally ordered them according to their time of origin. Then they isolated 39 amino acid substitutions that occurred in different timelines and substituted them in a genetic background that approximated the ancestral genotype. They found that 3 of the 39 substitutions significantly reduced the fitness of the ancestral background. Compensatory mutations are new mutations that arise and have a positive or neutral impact on a populations fitness. Previous research has shown that populations have can compensate detrimental mutations. Burch and Chao tested Fisher's geometric model of adaptive evolution by testing whether bacteriophage φ6 evolves by small steps. Their results showed that bacteriophage φ6 fitness declined rapidly and recovered in small steps . Viral nucleoproteins have been shown to avoid cytotoxic T lymphocytes (CTLs) through arginine-to glycine substitutions. This substitution mutations impacts the fitness of viral nucleoproteins, however compensatory co-mutations impede fitness declines and aid the virus to avoid recognition from CTLs. Mutations can have three different effects; mutations can have deleterious effects, some increase fitness through compensatory mutations, and lastly mutations can be counterbalancing resulting in compensatory neutral mutations.
=== Cyberwarfare and cyber sanctions === In addition to retaliatory digital attacks, countries can respond to cyber attacks with cyber sanctions. Sometimes, it is not easy to detect the attacker, but suspicions may focus on a particular country or group of countries. In these cases, unilateral and multilateral economic sanctions can be used instead of cyberwarfare. For example, the United States has frequently imposed economic sanctions related to cyber attacks. Two Executive Orders issued during the Obama administration, EO 13694 of 2015 and EO 13757 of 2016, specifically focused on the implementation of the cyber sanctions. Subsequent US presidents have issued similar Executive Orders. The US Congress has also imposed cyber sanctions in response to cyberwarfare. For example, the Iran Cyber Sanctions Act of 2016 imposes sanctions on specific individuals responsible for cyber attacks.
== Zailin == Zailin is the brand name for the company's line of generic prescription amoxicillin antibiotics, which includes capsules, dispersible tablets, granules and injection. During the year ended December 31, 2007, revenues of Zailin accounted for 21% of the company's product revenues.
DMT is used either in pure form or in the form of naturally sourced materials. It occurs naturally in many plants, among the more notable species including Psychotria viridis, Mimosa tenuiflora, and Diplopterys cabrerana. The drug is often present alongside its close analogues 5-MeO-DMT (mebufotenin) and bufotenin (5-HO-DMT). It has widely been used as an entheogen or for shamanistic purposes in Central and South America, for instance among Amazonian peoples. This includes as the traditional beverage ayahuasca and other forms. Ayahuasca is a boiled mixture of different plants, including a DMT-containing plant like Psychotria viridis, Psychotria carthagenensis, or Diplopterys cabrerana together with another plant known as Banisteriopsis caapi. A variety of different recipes may be used to make the brew. DMT is usually the main active constituent of ayahuasca, but ayahuasca is sometimes also brewed with plants that do not contain DMT. The drug is also found as a minor alkaloid in hallucinogenic snuffs such as those made from Virola or Anadenanthera plant materials but in which the major active drugs are instead 5-MeO-DMT and/or bufotenin. In addition to its use as an entheogen, DMT is used recreationally. DMT is not orally active on its own and is given by parenteral administration, such as smoking, intramuscular injection, subcutaneous injection, or intravenous injection. Other routes like intranasal, buccal, or rectal administration have also been tried but were all reported to be inactive.
Sources: en.wikipedia.org
== Awards == Major Awards 1. Young Scientist Medal (1988), by the Indian Science Congress Association, India. 2. INSA Young Scientist Medal (1991), by the Indian National Science Academy, New Delhi. 3. CRSI Bronze Medal (2002), by the Chemical Research Society of India. 4. MRSI Medal (2007), by Material Research Society of India. 5. Shanti Swarup Bhatnagar Prize (2007), awarded by CSIR, Govt. India. 6. DAE Outstanding Researcher Award (2009), awarded by Dept. Atomic Energy, Govt. India. 7. Thomson Reuters Research Excellence-India Research Front Award (2009). 8. The Infosys Prize for Physical Sciences 2012 by Infosys Science Foundation. 9. Khwarizmi International Award 2012 by Iranian Organisation for Science and Technology. 10. Swadeshi Innovation Award 2012 by the Swadeshi Science Movement, Kerala. 11. Sri Vidyadhiraja Samskrithi Puraskaram 2013 by Panmana Ashram, Quilon, Kerala. 12. CRSI Silver Medal 2013 by Chemical Research Society of India. 13. TWAS Chemistry Prize 2013 by The World Academy of Sciences, Trieste, Italy. 14. ISAS National Award for Excellence in Science and Technology 2014 by Indian Society of Analytical Scientists. 15. CHEMTECH CEW Award 2015 for Leadership and Excellence in Research and Development. 16. J. C. Bose National Fellowship, 2015, DST, Govt. India. 17. Web of Science-India Research Excellence-Citation Award 2017 by Clarivate Analytics. 18. MRSI Distinguished Lectureship Award, 2019-20, by Materials Research Society of India. 19. Goyal Prize for Chemical Science, 2019, by Kurukshetra University. Other Honors 1.
=== Type 2 diabetes === There are contradictory reviews. From one, vitamin C supplementation cannot be recommended for management of type 2 diabetes. However, another reported that supplementation with high doses of vitamin C can decrease blood glucose, insulin and hemoglobin A1c.
==== Canaloplasty ==== Canaloplasty is a nonpenetrating procedure using microcatheter technology. To perform a canaloplasty, an incision is made into the eye to gain access to the Schlemm's canal, similarly to a viscocanalostomy. A microcatheter will circumnavigate the canal around the iris, enlarging the main drainage channel and its smaller collector channels through the injection of a sterile, gel-like material called viscoelastic. The catheter is then removed, and a suture is placed within the canal and tightened. By opening the canal, the pressure inside the eye may be relieved, although the reason is unclear, since the canal (of Schlemm) does not have any significant fluid resistance in glaucoma or healthy eyes. Long-term results are not available.
== Structure == Pyruvic acid crystallizes as the keto acid, not the enol. The six non-hydrogen atoms are nearly coplanar. More relevant to biochemistry is the structure of the pyruvate anion. Several salts of pyruvate have been examined by X-ray crystallography. These tests confirm that pyruvate anion also exists in the keto form.
While negotiating with Alpachi for the hostages' release, Umeko realizes the truth and clears his name, while her teammates rescue Alpachi's son and delete Goldom. Attika Alpachi is voiced by Bin Shimada. Shinnooian Hakutaku (シンノー星人ハクタク, Shinnō Seijin Hakutaku): A wise woman from Planet Shinoo, with knowledge of all space herbs, who occasionally assumes the form of a human teenage girl and possesses a third eye shaped like a red jewel. After the Dekarangers take her into their protective custody, she provides guidance to Sen-chan, becomes attracted to him, and raises money for their wedding. Hakutaku is voiced by Reiko Suzuki (鈴木 れい子, Suzuki Reiko) while her human form is portrayed by Narumi Konno (近野 成美, Kon'no Narumi). Bandarean Jeeva (バンダレ星人ジーバ, Bandare Seijin Jība): A physically imposing Oni-themed alien, and champion boxer in Durden's illegal fight club, from Planet Bandare. After consuming Durden's steroid, Megagesterine, and gaining wing-like horns on his arms and neck, Jeeva fights Hoji, who defeats him. Following this, Jeeva reformed and found work as the assistant director of a television station. Jeeva is voiced by Toshitsugu Takashina (高階 俊嗣, Takashina Toshitsugu). Slorpean Faraway (スロープ星人ファラウェイ, Surōpu Seijin Farawei): A small-time criminal from Planet Slorpe who resembles a ganguro girl and possesses proficient hacking skills.
Sources: en.wikipedia.org
No. Melanotan-2 is manufactured synthetically. The naturally occurring peptide in the same family is alpha-melanocyte-stimulating hormone, which the body produces as part of normal endocrine and neural signalling.
Both are synthetic analogues derived from the same parent hormone. Reference descriptions usually characterise afamelanotide as more selective for the MC1R subtype, whereas melanotan-2 is reported to interact with a wider range of melanocortin receptors.
Early studies explored melanocortin signalling and pigmentation, which later led to informal use of the label tanning peptide. That label is not a regulatory category and does not imply approved status for any purpose.
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.